XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact
The Pharma Data
JANUARY 27, 2021
Further to XPhyto’s press release dated January 18, 2021, the Company’s core milestones for this year include the commercialization of infectious disease diagnostics, the clinical validation of transdermal and sublingual drug formulations and continued investment in psychedelic medicine. About XPhyto Therapeutics Corp.
52 
Let's personalize your content